Instead, he chose to be the first person in Texas to try Inlexzo. Inlexzo is a chemotherapy that comes in a tube that looks ...

While the current approval focuses on the second-line setting, research is already moving into earlier stages of the ...

Investigators studied US trends in the diagnosis of variant histology bladder cancer using the National Cancer database.

The combination of Keytruda and Padcev is taking another major step toward securing its position as a leading therapy in the ...

Pat Finn, an actor best known for his roles on “Seinfeld” and “The Middle,” has died. Finn passed away Dec. 22, at age 60 of ...

What Is Zusduri Used For? Zusduri is used to treat a certain type of recurrent, persistent bladder cancer known as LG-IR-NMIBC. About 75% of people with bladder cancer present with non-muscle invasive ...

When you learn you have bladder cancer, it’s only natural to ask: "Can I survive this, for how long, and can I expect to be cured?" You may have searched online for survival rate information. These ...

Armed with new three-year data demonstrating the benefits of Anktiva in a specific patient subset, ImmunityBio is proving its ...

The Middle alum Pat Finn’s cause of death has been revealed. “It is with profound sadness and grief that the Finn family ...

Pat Finn, the actor who played Bill Norwood on the long-running sitcom The Middle, has died, according to family members and ...

ImmunityBio says Anktiva plus BCG showed durable survival and bladder preservation at 36 months in BCG-unresponsive bladder ...

Bladder cancer affects over 52,000 men and women in the United States on an annual basis, and more than 12,000 people die each year from this disease. It is the fourth most common cancer in men in ...